Acknowledgements This work was partially funded by the Italian Mi

Acknowledgements This work was partially funded by the Italian Ministry of Education and by SIGMA-TAU Industrie Farmaceutiche Riunite,

contract nr. DS/2007/C.R.n15 (Grants to G.R.). The iconographic work by Riccardo Risuleo is also acknowledged. References 1. Thisse B, Thisse C: Functions and regulations of fibroblast growth factor signaling Liproxstatin-1 purchase during embryonic development. Dev Biol 2005, 287: 390–402. Erratum in: Dev Biol. 2006 295 :294.CrossRefPubMed 2. Dailey L, Ambrosetti D, Mansukhani A, Basilico C: Mechanisms underlying differential responses to FGF signaling. Cytokine Growth Factor 2005, 16: 233–247.CrossRef 3. Acevedo VD, Ittmann M, Spencer DM: Paths of FGFR-driven tumorigenesis. Cell Cycle 2009, 8: 580–588.CrossRefPubMed 4. Eswarakumar VP, Lax I, Schlessinger J: Cellular signaling by fibroblast growth factor receptors. Cytokine Growth Factor 2005, 16: 139–149.CrossRef AL3818 mouse 5. Böttcher

RT, Niehrs C: Fibroblast growth factor signaling during early vertebrate development. Endocr Rev 2005, 26: 63–77.CrossRefPubMed 6. L’Hôte CG, Knowles MA: Cell responses to FGFR3 signalling: growth, differentiation and apoptosis. Exp Cell Res 2005, 304: 417–31.CrossRefPubMed 7. Mohammadi M, McMahon G, Sun L, Tang C, Hirth P, Yeh BK, Hubbard SR, Schlessinger J: Structures of the tyrosine kinase domain of fibroblast growth factor receptor in complex with inhibitors. Science 1997, 276: 955–960.CrossRefPubMed 8. Ohshima M, Yamaguchi Y, Kappert K, Micke P, Otsuka K: bFGF rescues imatinib/STI571-induced apoptosis of sis-NIH3T3 fibroblasts. Biochem Biophys Res Commun 2009, 381: 165–170.CrossRefPubMed 9. Fischer H, Taylor N, Allerstorfer S, Grusch M, Sonvilla G, Temozolomide mw Holzmann K, Setinek U, Elbling L, Cantonati H, Grasl-Kraupp B, Gauglhofer C, Marian B, Micksche M, Berger W: Fibroblast growth factor receptor-mediated signals contribute to the malignant phenotype of non-small cell lung cancer cells: therapeutic 6-phosphogluconolactonase implications and synergism with epidermal growth factor receptor inhibition. Mol Cancer Ther 2008, 7: 3408–3419.CrossRefPubMed 10. Calandrella N, Risuleo G, Scarsella G, Mustazza C, Castelli M, Galati F, Giuliani A, Galati G: Reduction of cell proliferation

induced by PD166866: an inhibitor of the basic fibroblast growth factor. J Exp Clin Cancer Res 2007, 3: 405–409. 11. Piccioni F, Borioni A, Delfini M, Del Giudice MR, Mustazza C, Rodomonte A, Risuleo G: Metabolic alterations in cultured mouse fibroblasts induced by aninhibitor of the tyrosine kinase receptor Fibroblast Growth Factor Receptor 1. Anal Biochem 2007, 367: 111–121.CrossRefPubMed 12. Mosmann T: Rapid colorimetric assay for cellular grow and survival: application to proliferation and cytotoxixity assay. J Immunol Methods 1983, 65: 55–63.CrossRefPubMed 13. Marnett LJ, Riggins JN, West JD: Endogenous generation of reactive oxidants and electrophiles and their reactions with DNA and protein. J Clin Invest 2003, 111: 583–593.PubMed 14.

Comments are closed.